Literature DB >> 10594738

Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads.

R Wanke1, S Milz, N Rieger, L Ogiolda, I Renner-Müller, G Brem, W Hermanns, E Wolf.   

Abstract

Growth hormone has been shown to possess stimulatory effects on various connective tissues. We observed that skin growth in male rat phosphoenolpyruvate carboxykinase-bovine growth hormone transgenic mice (serum growth hormone levels: 740-1940 ng per ml) is progressive with age, resulting in an "oversized coat" phenotype with a marked increase in absolute and relative skin weight and surface area, and in thickness of the dermis. Histologic changes include severe dermal fibrosis and replacement of subdermal adipose tissue by fibrous tissue. Apart from an increase in skin surface area, these changes were not noted in female transgenic mice, arguing for a specific interaction of growth hormone with male sex hormones. To clarify this point, 6 wk old male transgenic mice and control mice were castrated and compared with their noncastrated counterparts in parameters of skin growth at an age of 8 mo. The skin weight of castrated transgenic mice was smaller (p < 0.01) than that of intact transgenic mice both absolutely and relative to body weight. The relative skin weight of castrated transgenic mice was in the same range as in intact and castrated control mice. Absolute and relative skin area of castrated transgenic mice was greater (p < 0. 001 and p < 0.05) than in controls but lower than in intact transgenic mice (p < 0.001 and p < 0.05). When compared with control mice, intact transgenic mice displayed an increase (p < 0.01) in the thickness of dermis. In castrated transgenic mice the thickness of the dermis was in the same range as in control mice. Our findings demonstrate a specific interaction of growth hormone with male sex hormones resulting in a marked stimulation of skin growth.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10594738     DOI: 10.1046/j.1523-1747.1999.00807.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  The valency of fatty acid conjugates impacts siRNA pharmacokinetics, distribution, and efficacy in vivo.

Authors:  Annabelle Biscans; Andrew Coles; Dimas Echeverria; Anastasia Khvorova
Journal:  J Control Release       Date:  2019-03-30       Impact factor: 9.776

Review 2.  Adipocytes in skin health and disease.

Authors:  Guillermo Rivera-Gonzalez; Brett Shook; Valerie Horsley
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

3.  Reproductive parameters of double transgenic zebrafish (Danio rerio) males overexpressing both the growth hormone (GH) and its receptor (GHR).

Authors:  Ana Cecilia Gomes Silva; Daniela Volcan Almeida; Bruna Felix Nornberg; Jessica Ribeiro Pereira; Diego Martins Pires; Carine Dahl Corcini; Antonio Sergio Varela Junior; Luis Fernando Marins
Journal:  Transgenic Res       Date:  2016-10-14       Impact factor: 2.788

Review 4.  Claims for the anabolic effects of growth hormone: a case of the emperor's new clothes?

Authors:  M J Rennie
Journal:  Br J Sports Med       Date:  2003-04       Impact factor: 13.800

5.  Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo.

Authors:  Annabelle Biscans; Andrew Coles; Reka Haraszti; Dimas Echeverria; Matthew Hassler; Maire Osborn; Anastasia Khvorova
Journal:  Nucleic Acids Res       Date:  2019-02-20       Impact factor: 16.971

6.  Docosanoic acid conjugation to siRNA enables functional and safe delivery to skeletal and cardiac muscles.

Authors:  Annabelle Biscans; Jillian Caiazzi; Nicholas McHugh; Vignesh Hariharan; Manish Muhuri; Anastasia Khvorova
Journal:  Mol Ther       Date:  2020-12-19       Impact factor: 11.454

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.